PIII vs. SHCR, IMAQ, BLEU, DCGO, CBRG, TALK, WGS, INNV, PNTG, and ZVRA
Should you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Sharecare (SHCR), International Media Acquisition (IMAQ), bleuacacia (BLEU), DocGo (DCGO), Chain Bridge I (CBRG), Talkspace (TALK), GeneDx (WGS), InnovAge (INNV), The Pennant Group (PNTG), and Zevra Therapeutics (ZVRA).
Sharecare (NASDAQ:SHCR) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings, risk and community ranking.
Sharecare presently has a consensus target price of $1.00, suggesting a potential upside of 29.57%. P3 Health Partners has a consensus target price of $4.75, suggesting a potential upside of 606.95%. Given Sharecare's stronger consensus rating and higher probable upside, analysts clearly believe P3 Health Partners is more favorable than Sharecare.
P3 Health Partners has higher revenue and earnings than Sharecare. Sharecare is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.
35.1% of Sharecare shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 29.3% of Sharecare shares are owned by company insiders. Comparatively, 17.1% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Sharecare had 10 more articles in the media than P3 Health Partners. MarketBeat recorded 17 mentions for Sharecare and 7 mentions for P3 Health Partners. Sharecare's average media sentiment score of 0.80 beat P3 Health Partners' score of -0.04 indicating that P3 Health Partners is being referred to more favorably in the news media.
Sharecare has a beta of 0.26, suggesting that its stock price is 74% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.
P3 Health Partners has a net margin of -4.97% compared to P3 Health Partners' net margin of -30.71%. P3 Health Partners' return on equity of -19.28% beat Sharecare's return on equity.
Sharecare received 2 more outperform votes than P3 Health Partners when rated by MarketBeat users. Likewise, 35.29% of users gave Sharecare an outperform vote while only 28.57% of users gave P3 Health Partners an outperform vote.
Summary
P3 Health Partners beats Sharecare on 10 of the 18 factors compared between the two stocks.
Get P3 Health Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PIII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
P3 Health Partners Competitors List
Related Companies and Tools
